Literature DB >> 25897652

Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.

Maciej J Stawikowski1,2, Roma Stawikowska1,2, Gregg B Fields1,2,3.   

Abstract

Although collagenolytic matrix metalloproteinases (MMPs) possess common domain organizations, there are subtle differences in their processing of collagenous triple-helical substrates. In this study, we have incorporated peptoid residues into collagen model triple-helical peptides and examined MMP activities toward these peptomeric chimeras. Several different peptoid residues were incorporated into triple-helical substrates at subsites P3, P1, P1', and P10' individually or in combination, and the effects of the peptoid residues were evaluated on the activities of full-length MMP-1, MMP-8, MMP-13, and MMP-14/MT1-MMP. Most peptomers showed little discrimination between MMPs. However, a peptomer containing N-methyl Gly (sarcosine) in the P1' subsite and N-isobutyl Gly (NLeu) in the P10' subsite was hydrolyzed efficiently only by MMP-13 [nomenclature relative to the α1(I)772-786 sequence]. Cleavage site analysis showed hydrolysis at the Gly-Gln bond, indicating a shifted binding of the triple helix compared to the parent sequence. Favorable hydrolysis by MMP-13 was not due to sequence specificity or instability of the substrate triple helix but rather was based on the specific interactions of the P7' peptoid residue with the MMP-13 hemopexin-like domain. A fluorescence resonance energy transfer triple-helical peptomer was constructed and found to be readily processed by MMP-13, not cleaved by MMP-1 and MMP-8, and weakly hydrolyzed by MT1-MMP. The influence of the triple-helical structure containing peptoid residues on the interaction between MMP subsites and individual substrate residues may provide additional information about the mechanism of collagenolysis, the understanding of collagen specificity, and the design of selective MMP probes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25897652      PMCID: PMC4511165          DOI: 10.1021/acs.biochem.5b00110

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  69 in total

1.  The role of the C-terminal domain in collagenase and stromelysin specificity.

Authors:  G Murphy; J A Allan; F Willenbrock; M I Cockett; J P O'Connell; A J Docherty
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

2.  Crystal and molecular structure of a collagen-like peptide at 1.9 A resolution.

Authors:  J Bella; M Eaton; B Brodsky; H M Berman
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

3.  Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen.

Authors:  B Steffensen; U M Wallon; C M Overall
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

4.  Susceptibility of type I collagen containing mutated alpha 1(1) chains to cleavage by human neutrophil collagenase.

Authors:  K A Hasty; H Wu; M Byrne; M B Goldring; J M Seyer; R Jaenisch; S M Krane; C L Mainardi
Journal:  Matrix       Date:  1993-05

5.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

6.  Generation of collagenase-resistant collagen by site-directed mutagenesis of murine pro alpha 1(I) collagen gene.

Authors:  H Wu; M H Byrne; A Stacey; M B Goldring; J R Birkhead; R Jaenisch; S M Krane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Fragments of human fibroblast collagenase. Purification and characterization.

Authors:  I M Clark; T E Cawston
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

8.  Fragmentation of human polymorphonuclear-leucocyte collagenase.

Authors:  V Knäuper; A Osthues; Y A DeClerck; K E Langley; J Bläser; H Tschesche
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

9.  Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.

Authors:  Dmitriy Minond; Janelle L Lauer-Fields; Hideaki Nagase; Gregg B Fields
Journal:  Biochemistry       Date:  2004-09-14       Impact factor: 3.162

10.  Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.

Authors:  Y Itoh; S Binner; H Nagase
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

View more
  5 in total

1.  Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.

Authors:  Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Lillian Onwuha-Ekpete; Kelli Harmon; Trista Robichaud; Rita Fuerst; Roma Stawikowska; Bjorn Steffensen; William Roush; Hector R Wong; Gregg B Fields
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

2.  Tricine as a convenient scaffold for the synthesis of C-terminally branched collagen-model peptides.

Authors:  Maciej J Stawikowski; Gregg B Fields
Journal:  Tetrahedron Lett       Date:  2017-12-05       Impact factor: 2.415

Review 3.  Assessing the range of enzymatic and oxidative tunability for biosensor design.

Authors:  Hattie C Schunk; Derek S Hernandez; Mariah J Austin; Kabir S Dhada; Adrianne M Rosales; Laura J Suggs
Journal:  J Mater Chem B       Date:  2020-04-29       Impact factor: 6.331

4.  Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma-Induced Osteolysis and Reduces Overall Survival.

Authors:  Chen Hao Lo; Gemma Shay; Jeremy J McGuire; Tao Li; Kenneth H Shain; Jun Yong Choi; Rita Fuerst; William R Roush; Anna M Knapinska; Gregg B Fields; Conor C Lynch
Journal:  Cancer Res       Date:  2021-02-01       Impact factor: 12.701

5.  Wharton's jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis.

Authors:  Olfat A Hammam; Nagwa Elkhafif; Yasmeen M Attia; Mohamed T Mansour; Mohamed M Elmazar; Rania M Abdelsalam; Sanaa A Kenawy; Aiman S El-Khatib
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.